Delcath Systems registers $10 million of stock for public units sale

Bookrunner Roth helps to sell units of a common share and two warrants

By Devika Patel

Knoxville, Tenn., June 15 – Delcath Systems Inc. will conduct a $10 million offering of units with a 30-day greenshoe option, according to a Form S-1 filed Monday with the Securities and Exchange Commission. The company has registered up to $10 million of stock.

The units will each consist of one common share and two warrants. One warrant expires in 90 days and the other expires in five years.

Roth Capital Partners is the bookrunner.

Proceeds will be used for clinical studies, commercialization, research, capital expenditures, working capital and other general corporate purposes.

Delcath is based in Stamford, Conn., where it develops isolated perfusion technology for organ or region-specific delivery of therapeutic agents.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.